SMTL ID : 8g6z.1

JAK2 crystal structure in complex with Compound 13

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.45 Å

Oligo State

homo-dimer

Ligands

2 x YSI: (3R)-3-cyclopentyl-3-[(4M)-4-{5-methyl-2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrimidin-4-yl}-1H-pyrazol-1-yl]propanenitrile(Non-covalent)

YSI.1: 18 residues within 4Å: Chain A: L.41, G.42, K.43, G.44, G.47, V.49, A.66, M.115, E.116, Y.117, L.118, P.119, G.121, R.166, N.167, L.169, G.179, D.180 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:V.49, A:V.49, A:A.66, A:L.169, A:D.180 Hydrogen bonds: A:L.118, A:L.118, A:G.179 YSI.2: 19 residues within 4Å: Chain B: L.41, G.42, K.43, G.44, N.45, G.47, V.49, A.66, M.115, E.116, Y.117, L.118, P.119, G.121, R.166, N.167, L.169, G.179, D.180 8 PLIP interactions: 8 interactions with chain B Hydrophobic interactions: B:V.49, B:V.49, B:A.66, B:L.169, B:D.180 Hydrogen bonds: B:L.118, B:L.118, B:G.179

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.3: 3 residues within 4Å: Chain B: K.43, G.44, R.166 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:K.43, B:R.166

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gordhan, H.M. et al., Eyes on Topical Ocular Disposition: The Considered Design of a Lead Janus Kinase (JAK) Inhibitor That Utilizes a Unique Azetidin-3-Amino Bridging Scaffold to Attenuate Off-Target Kinase Activity, While Driving Potency and Aqueous Solubility. J.Med.Chem. (2023)

Release Date

2023-06-21

Peptides

Tyrosine-protein kinase JAK2: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Tyrosine-protein kinase JAK2